NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

NAMS Stock Analysis: Buy, Sell, or Hold?

$20.72
+1.54 (+8.03%) ▲
5d: -1.0% 30d: +2.63% 90d: -22.31%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
44/100
Position
FAIR
30-Day Fair Range
$19.53 – $21.60
Position: FAIR
Forward P/E & Valuation
-11.4x
Next 12M consensus est.
Wall Street Target
$50.32
+142.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$17.90 / $22.26
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: NAMS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Nov 6, 2026 at $18.98 · last confirmed Nov 6, 2026

Strength: 4.6/10

Get Alerted When NAMS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: NAMS is currently trading at $20.72, which is considered fair relative to its 30-day fair value range of $19.53 to $21.60.

Technical Outlook: Technically, NAMS is in a strong downtrend. Immediate support is located at $17.90, while resistance sits at $22.26. The stock is showing strong short-term momentum, up 8.0% recently.

Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $50.32 (+142.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $19.53 - $21.60
Company Quality Score 44/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 80.0%

Trading Range & Key Levels

30-Day Trading Range $19.53 - $21.60
Current vs Trading Range FAIR
Support Level $17.90
Resistance Level $22.26
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding NAMS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (50/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+8.0%)
  • BULLISH: Trading 142.8% below Wall St target ($50.32)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -11.43
Wall Street Target $50.32 (+142.8%)
Revenue Growth (YoY) 5406.9%
Share NAMS Analysis

Share this live NAMS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (NAMS)

Bullish 3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate $NAMS was oversold and saw significant bullish sentiment with an 8% price increase on 2.6M shares traded.
Key Retail Themes: oversold condition bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:19 AM ET
Data refreshes hourly during market hours. Next update: 3:19 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for NAMS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
IONS
Ionis Pharmaceuticals Inc
STRONG BUY
25 analysts
$84 50 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
JANX
Janux Therapeutics Inc
STRONG BUY
18 analysts
$32 51 HOLD
GPCR
Structure Therapeutics Iâ€Ļ
STRONG BUY
16 analysts
$107 50 HOLD
ABVX
Abivax SA American Deposâ€Ļ
STRONG BUY
12 analysts
$164 63 BUY

Advanced NAMS Option Strategies

Professional options setups generated by AI based on today's NAMS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive NAMS Research Pages
NAMS Technical Chart NAMS Price Prediction NAMS Intrinsic Value DCF NAMS Earnings Date Why is NAMS Moving Today? NAMS Investment Advisor NAMS Fair Price Analyzer NAMS Options Chain NAMS Options Advisor NAMS Options Analysis NAMS Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals